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Purpose: Opacification of hydrophilic acrylic intraocular lenses (IOLs) is an emerging 
complication following Descemet stripping automated endothelial keratoplasty (DSAEK). We 
report six cases and review the current literature.
Methods: In this retrospective, noncomparative, observational case series, patients with IOL 
opacification after previous DSAEK surgery were identified from corneal clinic records. Case 
notes were reviewed for demographic details, indication for DSAEK, IOL model, incidence of 
rebubbling, and postoperative course.
Results: Six patients developed IOL opacification after DSAEK. All patients had Fuchs’ 
endothelial dystrophy and had previously received hydrophilic acrylic IOL models. Central 
anterior IOL opacification was noted in all six cases. Five cases (83%) had required rebubbling 
due to dislocated graft tissue, and one had an early postoperative intraocular pressure (IOP) 
rise. Five cases (83%) were managed conservatively, and one case with a failed graft underwent 
redo DSAEK and IOL exchange.
Conclusion: Repeated exposure to intracameral air, raised IOP, and other patient influences may 
be major etiological factors for IOL opacification after DSAEK. We advise avoiding hydrophilic 
acrylic IOL models in patients who may require future endothelial keratoplasty.
Keywords: IOL, DSAEK, lamellar keratoplasty, endothelial corneal transplantation
Introduction
The surgical treatment of corneal endothelial pathology has changed significantly with 
the evolution of posterior lamellar keratoplasty techniques and Descemet stripping 
automated endothelial keratoplasty (DSAEK) is now widely performed as the pro-
cedure of choice for corneal decompensation secondary to endothelial dysfunction.1 
DSAEK is associated with excellent visual outcomes, with less corneal astigmatism 
and a more rapid visual recovery compared to traditional penetrating keratoplasty 
(PKP).1,2
Complications of DSAEK are well-described, although the most common adverse 
events do not appear to be detrimental to the ultimate visual outcome.3 Reported 
complications include graft dislocation, graft rejection, primary graft failure, graft–
host interface opacification, pupillary block, cystoid macular edema, and epithelial 
ingrowth.2,3 It has only recently become apparent that intraocular lens (IOL) compli-
cations may occur in pseudophakic patients undergoing DSAEK, with a number of 
recent reports describing late IOL opacification.4–10 We report a series of six cases 
of late-onset IOL opacification in pseudophakic patients after DSAEK surgery, and 
review the current literature on this emerging complication.
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Methods
This study was a retrospective, noncomparative, observational 
case series. The institutional review board of the Research & 
Development Department, Heart Of England NHS Founda-
tion Trust, Birmingham, UK, ruled that approval was not 
required for this report. We reviewed clinic records from 
patients attending the corneal service at Solihull Hospital, 
Heart of England NHS Foundation Trust, Birmingham, UK. 
Pseudophakic patients who had undergone DSAEK and later 
diagnosed with IOL opacification between January 2010 and 
April 2014, inclusive, were identified from clinic records. 
Charts were reviewed for demographic data, diagnosis/indi-
cation for DSAEK, ocular comorbidity, date of prior cataract 
surgery, details of IOL implant, date and perioperative details 
of DSAEK surgery, and postoperative management. For 
patients who had undergone surgery at another institution 
before transfer of their case to our clinic, all surgical and 
perioperative records for both cataract and corneal procedures 
were obtained for these patients from the referring center.
Results
A total of six patients were identified with IOL opacification 
following DSAEK: three (50%) were male and the mean 
age was 75.6 years (range 71–81 years). Five of the patients 
had undergone DSAEK elsewhere, and had subsequently 
transferred to our unit for ongoing management. We are 
therefore unable to accurately calculate the incidence from 
our series. Indication for DSAEK was corneal decompensa-
tion secondary to Fuchs’ endothelial dystrophy (FED) in all 
cases, and all had previously undergone cataract surgery and 
implantation of hydrophilic acrylic IOL models. Five cases 
(83%) had required intracameral air injection (‘rebubbling’) 
for donor graft dislocation in the early postoperative 
(1–5 days) period. One patient who did not require rebubbling 
had a postoperative intraocular pressure (IOP) spike on day 2 
post-DSAEK, which was managed with oral and topical 
antihypertensive medical therapy. This patient subsequently 
developed a corticosteroid-induced rise in IOP 3 months post-
operatively, which settled after a switch to a less potent corti-
costeroid preparation. The standard postoperative medication 
regime after DSAEK included topical preservative-free 0.1% 
dexamethasone six times daily and 0.5% chloramphenicol 
four times daily for 4 weeks, and subsequently 0.1% dex-
amethasone four times daily for 3 months, tapered over 
3 months, and maintained on long-term 0.1% fluorometholone 
(FML). In all cases, IOL opacification was a central, crys-
talline opacity within the pupillary margin, diagnosed on 
average 32 months (range 5–80 months) after DSAEK. Five 
(83%) patients have been managed conservatively, and one 
patient with a subsequently failed corneal graft has recently 
undergone IOL exchange and redo DSAEK. Demographic, 
clinical, and relevant postoperative details are summarized 
in Table 1. Clinical images of two patients are illustrated in 
Figures 1 and 2, respectively.
Discussion
Opacification of IOLs is well-described and associated with 
many factors, including IOL production processes, surgical 
techniques, and metabolic conditions.11,12 There are recent 
reports of hydrophilic acrylic IOL opacification as an emerg-
ing late complication of DSAEK (Table 2).4–10 We identi-
fied six cases of central IOL opacification in pseudophakic 
patients after undergoing DSAEK for corneal decompen-
sation secondary to FED. Whilst the pathophysiology is 
incompletely understood, several features are evident that 
may enable greater comprehension of this phenomenon and 
result in changes to practice.
Anterior central IOL opacification after DSAEK was first 
described in three cases presenting between 7 and 18 months 
postoperatively.5 A further case presenting approximately 
18 months after a combined redo DSAEK and phacoemulsi-
fication with hydrophilic IOL underwent IOL explantation,9 
and analysis confirmed granular calcification in the central 
zone of the anterior IOL optic. Calcification has been a com-
mon feature of all the explanted IOLs analyzed and confirmed 
by X-ray spectroscopy and calcium-specific staining methods 
such as alizarin red.4,7–10 Histological examination of the 
explanted IOL from our Case 5 confirmed the presence of 
dystrophic calcification (Figure 2).
Our six patients had all been implanted with hydrophilic 
acrylic IOL models prior to undergoing DSAEK (Table 1), 
and published cases have also been exclusively associated 
with hydrophilic acrylic IOLs (Table 2). These IOLs all have 
a similar water content of 25.5%–26%, although different 
acrylic polymer compositions, suggesting that the class of IOL 
is important for the development of opacification, rather than 
the IOL model per se. Despite macroscopically similar clinical 
appearances of IOL calcification reported after intraocular gas, 
there are some differences in the microscopic appearance of 
the crystalline deposits between different IOL models, possi-
bly reflecting the individual IOL polymer ultrastructure.6–11
The use of intracameral air is an integral part of DSAEK 
surgery and rebubbling of an incompletely adherent graft 
in the early postoperative period is reported in the majority 
of cases that have developed IOL opacification (Table 2), 
suggesting that repeated exposure of the hydrophilic IOL 
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to intracameral air is responsible. Consistently, five cases 
in our series (83%) required repeat intracameral air injec-
tion within the first postoperative week. The largest series 
to date of IOL opacification after keratoplasty reported ten 
cases, including seven after DSAEK, one after deep anterior 
lamellar keratoplasty (DALK), and two after PKP.7 Six of 
the DSAEK cases (86%) underwent at least one rebubbling 
and the DALK case reported was also exposed to repeated 
intracameral air injections. A recent report described early 
postoperative rebubbling in all four cases of opacification 
of Rayner hydrophilic acrylic IOL models after DSAEK, 
accounting for 40% of cases rebubbled in this series.10 
Figure 1 IOL opacification after DSAEK (Case 4).
Notes: (A) Central crystalline opacification of the IOL (arrow). (B) Higher magnification view, demonstrating IOL opacity within pupillary margin (arrow).
Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; IOL, intraocular lens.
BA
Figure 2 IOL opacification after DSAEK (Case 5).
Notes: (A, B) Central crystalline opacification of the IOL (arrow; note poor view due to failed graft). (C) Explanted IOL with central calcification. (D) Higher magnification 
view showing anterior central IOL calcification.
Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; IOL, intraocular lens.
A B
C D
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Repeated exposure of hydrophilic IOLs to intracameral air 
or gas is therefore likely to be a major contributory factor to 
the development of calcification, and has also been described 
in other cases of IOL opacification, such as after SF6 and 
C3F8 gas fill for treatment of Descemet membrane detach-
ment after cataract surgery.13 Anterior central opacification 
with sparing of the posterior and peripheral IOL optic is a 
common feature and the pattern of opacification in our cases 
is comparable (Figures 1 and 2). The distribution of calci-
fication has been attributed to the presence of intracameral 
gas/air in contact with the anterior IOL surface and relative 
protection of the peripheral IOL by the iris.6 Interestingly, 
one case reportedly had a small area of opacification outside 
the pupillary region, corresponding to an area of preexisting 
iris atrophy, further supporting the notion of an etiological 
factor within the anterior chamber.6 The repeated presence of 
gas or air in the anterior chamber may induce ultrastructural 
changes on the IOL optic surface within the pupil margin, 
leading to increased IOL permeability to anterior chamber 
factors that combine with the IOL material to act as a focus 
for calcification.6,8 As newer surgical modifications and 
instruments are being developed, Descemet membrane 
endothelial keratoplasty (DMEK) has been gaining popular-
ity, although it is associated with high graft detachment rates 
of up to 63% in the early surgical learning curve.14 Whilst this 
rate tends to improve with experience,15 IOL opacification 
may be a potentially greater problem for surgeons perform-
ing DMEK or converting from DSAEK, which is associated 
with a lower incidence of graft dislocations.3,15
Factors other than the repeated presence of intracam-
eral air may also contribute to the development of IOL 
opacification, as not all reported cases of post-DSAEK 
IOL calcification have been rebubbled in the postoperative 
period.5,7,9 IOL opacification is not an inevitable sequel to 
rebubbling. For example, a series examining 29 DSAEK 
cases requiring rebubbling did not mention IOL opacity,16 
and several smaller series of donor graft dislocations being 
managed with rebubbling have similarly failed to describe 
IOL changes.17,18 Use of hydrophobic acrylic or other IOL 
materials in these cohorts, underreporting of IOL compli-
cations, or other factors may account for the lack of IOL 
opacification described.
Prolonged breakdown of the blood–aqueous barrier 
(BAB) has been suggested as a contributory factor in IOL 
opacification, with air or postoperative inflammation induc-
ing a metabolic change in the anterior chamber, leading to 
an increase in aqueous protein, cells, and calcium content.5,7 
Repeated air/gas tamponade may then drive calcium-rich T
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aqueous into hydrophilic IOL substance with subsequent 
crystallization.6,8 One of the cases in our cohort (Case 5) 
developed IOL opacification in an eye in which the 
endothelial graft had failed several years previously, and it 
is therefore possible that prolonged low-grade intraocular 
inflammation was unidentified behind a cloudy cornea. Of 
note, this patient developed significant band keratopathy 
which required laser phototherapeutic keratectomy (PTK) in 
the 2 years after DSAEK. He had a past medical history of 
inflammatory bowel disease, requiring surgical colectomy, 
and had also previously been prescribed antipsychotic medi-
cation, and these factors may have influenced his metabolic 
status and propensity to calcification, although systemic 
calcium levels were not raised.
The postoperative course of published cases has been 
variable. Of the three cases reported by Patryn et al5 only 
one had been rebubbled, and the other two had very minimal 
and short-lived intraocular inflammation. The seven DSAEK 
case series all had complicated postoperative courses with 
rebubbling and intraocular inflammation, and even the one 
case that was not rebubbled had a prolonged anterior chamber 
inflammatory reaction and posterior synechiae.7 Schmidinger 
et al reported the presence of posterior synechiae in their case, 
which did not undergo rebubbling.9 Our single case (Case 4) 
who did not require rebubbling had a spike in IOP in the 
immediate postoperative period and a later corticosteroid-
induced IOP rise. Whilst the influence of raised IOP has not 
been widely considered, it is possible that IOP raised above a 
certain threshold may be an initiating event for anterior cham-
ber factors to induce IOL calcification. We cannot rule out the 
possibility that IOP or antiglaucoma medications may be con-
tributing factors. Thus, prolonged intraocular inflammation, 
raised IOP, or other patient metabolic factors may increase the 
risk of developing IOL opacification after DSAEK.
Whilst there are many indications for endothelial trans-
plantation, all the patients we identified had a diagnosis of 
FED. Furthermore, over 90% of reported cases have occurred 
in FED patients (Table 2),4–10 although IOL opacification 
after DSAEK has also been described in patients with pseu-
dophakic bullous keratopathy and Axenfeld–Rieger’s ante-
rior segment dysgenesis.8,19 It is possible that the underlying 
ocular condition itself may play a role in the pathogenesis 
of IOL opacification after DSAEK. FED is not considered 
to be an inflammatory disease, but it is conceivable that dif-
ferences in aqueous humor proteome in FED patients could 
predispose to IOL calcification.20 Furthermore, differential 
expression of genes related to ion transport, pump function, 
and stress response has been reported in the corneal endothe-
lium of FED patients compared to normal controls.21 Altered 
expression of aquaporins and solute transporters has also been 
reported in FED and PBK patients and further understanding 
of the genetic basis of corneal endothelial conditions may 
reveal other potential patient-related factors.22,23
Management of IOL opacification after DSAEK depends 
on the nature of the patient’s symptoms. Where intervention 
is indicated, neodymium-doped yttrium aluminum garnet 
(Nd:YAG) laser has failed to disperse the calcification opacity 
(Table 2).4–9 However, it should be considered that Nd:YAG 
laser treatment of the posterior capsule may compromise a 
safe IOL exchange if subsequently required.7 Attempts to 
surgically remove the opacity have also failed (Table 2),5–9 
reflecting the fact that the opacity is not merely a surface 
membrane but calcification within the IOL substance. IOL 
exchange is the only intervention that has enabled visual 
improvement (Table 2),4–10 and may require iris-fixated or 
sutured/glued IOL in cases where capsular integrity is insuf-
ficient for in-the-bag or sulcus implantation.8,24
In summary, we report six cases of IOL opacification after 
DSAEK, of which the majority required rebubbling of the 
dislocated donor endothelial graft in the early postoperative 
period. Repeated exposure to intracameral air is likely to be a 
significant etiological factor, although excessive postoperative 
inflammation, raised IOP, or other local or systemic factors may 
also contribute. Steps should be taken to minimize IOP spikes 
and inflammation. We suggest that hydrophilic IOL models 
should be avoided in patients undergoing cataract surgery who 
are at risk of postoperative corneal decompensation. Further-
more, as lamellar keratoplasty is now the treatment of choice 
for endothelial dysfunction, it is important that clinicians are 
alert to the emergence of this newly reported late complication 
in pseudophakic patients with hydrophilic IOLs.
Acknowledgment
This manuscript is derived from a poster abstract submitted 
to the American Academy of Ophthalmology, Chicago, IL, 
USA, October 18–21, 2014.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Price MO, Price FW. Descemet’s stripping endothelial keratoplasty. Curr 
Opin Ophthalmol. 2007;18(4):290–294.
2. National Institute for Health and Care Excellence. Corneal endothelial 
transplantation. [IPG304] 2009;1–10. Available from: https://www.nice.
org.uk/guidance/ipg304. Accessed January 6, 2015.
3. Lee BL, Jacobs DS, Musch DC, Kaufman SC, Reinhart WJ, Shtein RM. 
Descemet’s stripping endothelial keratoplasty: safety and outcomes: a 
report by the American Academy of Ophthalmology. Ophthalmology. 
2009;116(9):1818–1830.
Clinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.
Clinical Ophthalmology 2015:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
283
IOL opacification after DSAEK
 4. Werner L, Wilbanks G, Ollerton A, Michelson J. Localized calcification 
of hydrophilic acrylic intraocular lenses in association with intracameral 
injection of gas. J Cataract Refract Surg. 2012;38(4):720–721.
 5. Patryn E, van der Meulen IJ, Lapid-Gortzak R, Mourits M, Nieuwendaal CP. 
Intraocular lens opacifications in Descemet stripping endothelial ker-
atoplasty patients. Cornea. 2012;31(10):1189–1192.
 6. Dhittal A, Spalton DJ, Goyal S, Werner L. Calcification in hydrophilic 
intraocular lenses associated with injection of intraocular gas. Am J 
Ophthalmol. 2012;153(6):1154–1160.e1.
 7. Neuhann IM, Neuhann TF, Rohrbach JM. Intraocular lens calcification 
after keratoplasty. Cornea. 2013;32(4):e6–e10.
 8. Fellman MA, Werner L, Liu ET, et al. Calcification of a hydrophilic 
acrylic intraocular lens after Descemet-stripping endothelial kerato-
plasty: case report and laboratory analyses. J Cataract Refract Surg. 
2013;39(5):799–803.
 9. Schmidinger G, Pemp B, Werner L. [Opacification of an intraocular 
lens: calcification of hydrophilic intraocular lenses after gas tamponade 
of the anterior chamber]. Ophthalmologe. 2013;110(11):1066–1068. 
German.
10. De Cock R, Fajgenbaum MA. Calcification of Rayner hydrophilic 
acrylic intra-ocular lenses after Descemet’s stripping automated 
endothelial keratoplasty. Eye (Lond). 2014;28(11):1383–1384.
11. Werner L. Causes of intraocular lens opacification or discoloration. 
 J Cataract Refract Surg. 2007;33(4):713–726.
12. Werner L. Calcification of hydrophilic acrylic intraocular lenses. Am 
J Ophthalmol. 2008;146(3):341–343.
13. Saeed MU, Singh AJ, Morrell AJ. Sequential Descemet’s membrane 
detachments and intraocular lens haze secondary to SF6 or C3F8. Eur 
J Ophthalmol. 2006;16(5):758–760.
14. Price MO, Giebel AW, Fairchild KM, Price FW Jr. Descemet’s mem-
brane endothelial keratoplasty: prospective multicenter study of visual 
and refractive outcomes and endothelial survival. Ophthalmology. 
2009;116(12):2361–2368.
15. Dirisamer M, Ham L, Dapena I, et al. Efficacy of descemet mem-
brance endothelial keratoplasty; clinical outcome of 200 con-
secutive cases after a learning curve of 25 cases. Arch Ophthalmol. 
2011;129(11):1435–1443.
16. Clements JL, Bouchard CS, Lee WB, et al. Retrospective review of 
graft dislocation rate associated with descemet stripping automated 
endothelial keratoplasty after primary failed penetrating keratoplasty. 
Cornea. 2011;30(4):414–418.
17. Terry MA, Hoar KL, Wall J, Ousley P. Histology of dislocations in 
endothelial keratoplasty (DSEK and DLEK): a laboratory-based, sur-
gical solution to dislocation in 100 consecutive DSEK cases. Cornea. 
2006;25(8):926–932.
18. Bahar I, Kaiserman I, McAllum P, Slomovic A, Rootman D. Com-
parison of posterior lamellar keratoplasty techniques to penetrating 
keratoplasty. Ophthalmology. 2008;115(9):1525–1533.
19. Park J, Habib N. Opacification of IOL implants following endothelial 
keratoplasty. Paper presented at: Congress of the ESCRS, October 2013; 
Amsterdam, Netherlands.
20. Richardson MR, Segu ZM, Price MO, et al. Alterations in the aqueous 
humor proteome in patients with Fuchs endothelial dystrophy. Mol Vis. 
2010;16:2376–2383.
21. Gottsch JD, Bowers AL, Margulies EH, et al. Serial analysis of gene 
expression in the corneal endothelium of Fuchs’ dystrophy. Invest 
Ophthalmol Vis Sci. 2003;44(2):594–599.
22. Kenney MC, Atilano SR, Zorapapel N, Holguin B, Gaster RN, Ljubimov AV. 
Altered expression of aquaporins in bullous keratopathy and Fuchs’ 
dystrophy corneas. J Histochem Cytochem. 2004;52(10):1341–1350.
23. Vithana EN, Morgan PE, Ramprasad V, et al. SLC4A11 mutations 
in Fuchs endothelial corneal dystrophy. Hum Mol Genet. 2008;17(5): 
656–666.
24. Kumar DA, Agarwal A. Glued intraocular lens: a major review on 
surgical technique and results. Curr Opin Ophthalmol. 2013;24(1): 
21–29.
